CELC
Price
$69.72
Change
+$2.65 (+3.95%)
Updated
Nov 3 closing price
Capitalization
3.41B
One day until earnings call
Intraday BUY SELL Signals
IMTX
Price
$7.08
Change
+$0.01 (+0.14%)
Updated
Nov 3 closing price
Capitalization
1.08B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs IMTX

CELC vs IMTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CELC vs. IMTX commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and IMTX is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CELC with price predictions
Nov 03, 2026

Momentum Indicator for CELC turns positive, indicating new upward trend

CELC saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In 86 of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CELC's RSI Oscillator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for CELC just turned positive on October 22, 2026. Looking at past instances where CELC's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.

Following a +5.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where CELC advanced for three days, in 249 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

CELC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for CELC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CELC's P/B Ratio (-266.922) is very low in comparison to the industry average of (3.051). P/E Ratio (-16.214) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. CELC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for IMTX with price predictions
Nov 03, 2026

IMTX's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for IMTX moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 28 of the 33 cases the stock moved higher. This puts the odds of a move higher at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for IMTX just turned positive on October 21, 2026. Looking at past instances where IMTX's MACD turned positive, the stock continued to rise in 39 of 50 cases over the following month. The odds of a continued upward trend are 78%.

Following a +2.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMTX advanced for three days, in 220 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

IMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMTX as a result. In 83 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for IMTX entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.695) is normal, around the industry mean (3.051). P/E Ratio (-4.450) is within average values for comparable stocks, (-0.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (125.677) among similar stocks. P/S Ratio (23.202) is also within normal values, averaging (439.647).

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. IMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
CELC vs IMTX: Fundamental Ratings
CELC
IMTX
OUTLOOK RATING
1..100
2285
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
7776
P/E GROWTH RATING
1..100
2321
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELC's Valuation (1) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for IMTX (34) in the null industry. This means that CELC’s stock grew somewhat faster than IMTX’s over the last 12 months.

CELC's Profit vs Risk Rating (62) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for IMTX (100) in the null industry. This means that CELC’s stock grew somewhat faster than IMTX’s over the last 12 months.

IMTX's SMR Rating (98) in the null industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that IMTX’s stock grew similarly to CELC’s over the last 12 months.

IMTX's Price Growth Rating (76) in the null industry is in the same range as CELC (77) in the Miscellaneous Commercial Services industry. This means that IMTX’s stock grew similarly to CELC’s over the last 12 months.

IMTX's P/E Growth Rating (21) in the null industry is in the same range as CELC (23) in the Miscellaneous Commercial Services industry. This means that IMTX’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCIMTX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (CELC: $69.72 vs. IMTX: $7.07)
Brand notoriety: CELC and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 66% vs. IMTX: 147%
Market capitalization -- CELC: $3.41B vs. IMTX: $1.08B
CELC [@Biotechnology] is valued at $3.41B. IMTX’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $134.53B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 2 FA rating(s) are green while IMTX’s FA Score has 1 green FA rating(s).

  • CELC’s FA Score: 2 green, 3 red.
  • IMTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while IMTX’s TA Score has 5 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 3 bearish.
  • IMTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CELC and IMTX are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а +2.42% price change this week, while IMTX (@Biotechnology) price change was -2.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.09%. For the same industry, the average monthly price growth was -12.05%, and the average quarterly price growth was -17.02%.

Reported Earning Dates

CELC is expected to report earnings on Nov 05, 2026.

IMTX is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-2.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with SLDB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.21%
SLDB - IMTX
53%
Loosely correlated
+4.67%
TSHA - IMTX
48%
Loosely correlated
+2.25%
ABEO - IMTX
47%
Loosely correlated
N/A
VIR - IMTX
47%
Loosely correlated
+2.00%
EDIT - IMTX
46%
Loosely correlated
+1.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHMD2.740.14
+5.38%
SCHMID GROUP N.V.
IRM116.691.51
+1.31%
Iron Mountain
CLMT47.330.60
+1.28%
Calumet Inc.
DARE0.65N/A
-0.76%
Dare Bioscience Inc.
ALRS34.35-0.28
-0.81%
Alerus Financial Corp